Monitoring of Chemotherapy Response in Malignant Pleural Mesothelioma Using Fluorodeoxyglucose Positron Emission Tomography

Internal Medicine - Japan
doi 10.2169/internalmedicine.47.1462
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Fluorodeoxyglucose-Positron Emission Tomography

English

Chemotherapy of Malignant Pleural Mesothelioma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1990English

Clinical Role of F-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Lung Cancer and Suspected Malignant Pleural Effusion

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Quantifying Myocardial Inflammation Using F18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis

Journal of Nuclear Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2014English

Relationship Between Tumorsize of Malignant Pleural Mesothelioma and Its Response to Chemotherapy

JOURNAL OF HEALTH SCIENCE
2007English

18f-Fluorodeoxyglucose Positron-Emission Tomography-Computed Tomography to Diagnose Recurrent Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

[18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Diagnosing Polymyositis/Dermatomyositis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Molecular Imaging of Infection With Positron Emission Tomography: Beyond Fluorodeoxyglucose

Nükleer Tıp Seminerleri
2017English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy